RIMS2 and acute lymphoblastic leukemia: In the present study, we developed a new lncRNA-mRNA signature (including lncRNA LINC00652 and its six coexpression genes, INSL3, NIPAL2, REN, RIMS2, RPRM, and SNAP91) in relapsed ALL patients based on WGCNA and LASSO analyses.